Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 210,223,277 papers from all fields of science
Search
Sign In
Create Free Account
tetraarsenic oxide
Known as:
arsenic oxide (As4O6)
, tetra-arsenic hexaoxide
, Tetraarsenic hexaoxide
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
arsenic trioxide
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Tetraarsenic hexoxide induces G2/M arrest, apoptosis, and autophagy via PI3K/Akt suppression and p38 MAPK activation in SW620 human colon cancer cells
A. Nagappan
,
W. Lee
,
+6 authors
Soon-Chan Hong
PLoS ONE
2017
Corpus ID: 1797432
Tetraarsenic hexoxide (As4O6) has been used in Korean folk medicines for the treatment of cancer, however its anti-cancer…
Expand
2015
2015
Tetraarsenic hexoxide demonstrates anticancer activity at least in part through suppression of NF-κB activity in SW620 human colon cancer cells.
W. Lee
,
J. Yun
,
+10 authors
G. Kim
Oncology Report
2015
Corpus ID: 13033873
Tetraarsenic hexoxide (As4O6) has been used in Korean traditional medicine for the treatment of cancer since the late 1980's, and…
Expand
2013
2013
Tetraarsenic oxide and cisplatin induce apoptotic synergism in cervical cancer.
J. Byun
,
D. Jeong
,
+7 authors
K. Kim
Oncology Report
2013
Corpus ID: 34075983
Tetraarsenic oxide (As4O6, TAO) is a new arsenic compound that inhibits cell growth and induces apoptosis in human…
Expand
2009
2009
Synergistic interaction between tetra-arsenic oxide and paclitaxel in human cancer cells in vitro.
W. Chung
,
B. Sung
,
Sangsoo Kim
,
H. Rhim
,
H. Kuh
International Journal of Oncology
2009
Corpus ID: 7725246
Similar to arsenic trioxide (As2O3), tetra-arsenic oxide (As4O6, TAO) has shown anti-proliferative and apoptosis-inducing effects…
Expand
Highly Cited
2007
Highly Cited
2007
Adsorption of arsenite and arsenate onto muscovite and biotite mica.
S. Chakraborty
,
M. Wolthers
,
D. Chatterjee
,
L. Charlet
Journal of Colloid and Interface Science
2007
Corpus ID: 26083367
2005
2005
Diarsenic and tetraarsenic oxide inhibit cell cycle progression and bFGF‐ and VEGF‐induced proliferation of human endothelial cells
S. Woo
,
Myung‐Jin Park
,
+7 authors
C. Rhee
Journal of Cellular Biochemistry
2005
Corpus ID: 45994519
Arsenic trioxide (As2O3, diarsenic oxide) has recently been reported to induce apoptosis and inhibit the proliferation of various…
Expand
2004
2004
Comparison of effects of As2O3 and As4O6 on cell growth inhibition and gene expression profiles by cDNA microarray analysis in SiHa cells.
W. Ahn
,
S. Bae
,
+8 authors
Yong-Wan Kim
Oncology Report
2004
Corpus ID: 27389075
An arsenical compound, As2O3 has been reported to be effective for treating acute leukemia and induce apoptosis in many different…
Expand
2004
2004
Reverse effects of tetraarsenic oxide on the angiogenesis induced by nerve growth factor in the rat cornea.
M. Yoo
,
Jong-Taek Kim
,
+7 authors
K. Seo
Journal of Veterinary Medical Science
2004
Corpus ID: 6707309
To compare the antiangiogenic effects of tetraarsenic oxide (As4O6) with those of diarsenic oxide (As2O3) in the rat cornea, rat…
Expand
2003
2003
Tetraarsenic oxide, a novel orally administrable angiogenesis inhibitor.
Myung‐Jin Park
,
I. Park
,
+6 authors
C. Rhee
International Journal of Oncology
2003
Corpus ID: 24231994
Arsenic compounds have been used to treat angiogenic diseases such as cancer, psoriasis, and rheumatoid arthritis in traditional…
Expand
2003
2003
Tetraarsenic oxide induces apoptosis in U937 leukemic cells through a reactive oxygen species-dependent pathway.
I. Park
,
Myung‐Jin Park
,
+8 authors
C. Rhee
International Journal of Oncology
2003
Corpus ID: 19779221
In the present study, we investigated the effect of tetraarsenic oxide (As4O6, 2,4,6,8,9,10-Hexaoxa-1,3,5,7-tetraarsatricyclo[3.3…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE